Date
- 2026 (5)
- 2025 (65)
- 2024 (100)
- 2023 (82)
- 2022 (65)
- 2021 (120)
- 2020 (152)
- 2019 (52)
- 2018 (54)
- 2017 (50)
- 2016 (4)
- 2015 (37)
- 2014 (22)
- 2013 (25)
- 2012 (13)
- 2011 (51)
- 2010 (45)
- 2009 (32)
- 2008 (27)
- 2007 (17)
- 2006 (21)
- 2005 (51)
- 2004 (12)
- 2003 (10)
- 2002 (10)
- 2001 (6)
- 2000 (5)
- 1999 (5)
- 1998 (9)
- 1997 (3)
- 1991 (3)
Sponsor content
1154 result(s) found, displaying 631 to 640
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SANDOZ VENLAFAXINE XR venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SANDOZ VENLAFAXINE XR venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PIPTAZ SANDOZ 4 g/ 0.5 g piperacillin (as sodium) 4g and tazobactam (as sodium) 0.5 g powder for injection bottle.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 16/12/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 16/12/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 16/12/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 16/12/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 16/12/2019
-
Cancellation by sponsorRequested by Sandoz Pty Ltd
-